To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.
To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.
Mind Cure Health is seeking to raise $3 million via the sale of 6.66 million units.
The Navy SEAL Foundation (NSF) recently pledged one of the organization’s largest single grants in its 20-year history to support a major Post Traumatic Stress Disorder (PTSD) study.
The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today.
Mind Cure's new Chief Science Officer (CSO) brings experience in drug research as well as natural product development.
Compass joins an international organization dedicated to advancing psychedelic drug research.
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.
Entheon Biomedical has announced that it expects to commence public trading on or about November 12th, symbol "ENBI".
Cybin Corp has completed its RTO and received approval to commence trading on the NEO Exchange (symbol "CYBN") and expects to begin trading on or about November 10th.
Pure Extracts is now trading under the symbol "PULL".
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now